Literature DB >> 19763675

Pap smears for men: a vision of the future?

S F Oon1, A Hanly, D C Winter.   

Abstract

BACKGROUND: Anal intraepithelial neoplasia (AIN) rarely receives as much publicity as its neighbouring orifice, the cervix. As in the cervix, intraepithelial neoplasias are precursors to cancer in the anal canal. AIN and cervical interstitial neoplasia (CIN) undergo dysplasia as a consequence of human papillomavirus (HPV) infection. Since the advent of screening with the Pap smear in CIN, cervical cancer has plummeted to a fifth of its initial incidence. Anal cancer, however, has been rising, with a predilection for human immunodeficiency virus-infected men. HPV causes a squamous epithelial dysplasia and converts healthy tissue into AINs of increasing severity until anal cancer manifests. CLINICAL CASE: This article describes a clinical case of anogenital HPV infection refractory to medical and surgical therapy. It also describes an effective surgical excision technique associated with a good cosmetic outcome.
CONCLUSIONS: The paper concludes by briefly discussing the implications of a national screening programme against AIN in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19763675     DOI: 10.1007/s11845-009-0340-6

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.

Authors:  J R Daling; N S Weiss; T G Hislop; C Maden; R J Coates; K J Sherman; R L Ashley; M Beagrie; J A Ryan; L Corey
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

Review 2.  Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.

Authors:  J M Palefsky
Journal:  Semin Oncol       Date:  2000-08       Impact factor: 4.929

3.  The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Authors:  S J Goldie; K M Kuntz; M C Weinstein; K A Freedberg; M L Welton; J M Palefsky
Journal:  JAMA       Date:  1999-05-19       Impact factor: 56.272

Review 4.  Screening for anal dysplasia associated with human papillomavirus.

Authors:  Wm Christopher Mathews
Journal:  Top HIV Med       Date:  2003 Mar-Apr

5.  Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

Authors:  Lisa G Johnson; Margaret M Madeleine; Laura M Newcomer; Stephen M Schwartz; Janet R Daling
Journal:  Cancer       Date:  2004-07-15       Impact factor: 6.860

6.  Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.

Authors:  Shalini L Kulasingam; Steve Benard; Ruanne V Barnabas; Nathalie Largeron; Evan R Myers
Journal:  Cost Eff Resour Alloc       Date:  2008-02-15

7.  The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting.

Authors:  J J Kim; B Andres-Beck; S J Goldie
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

  7 in total
  2 in total

1.  The potential of the male anal Pap smear.

Authors:  M B O'Connor
Journal:  Ir J Med Sci       Date:  2009-11-17       Impact factor: 1.568

2.  Comparative accuracy of anal and cervical cytology in screening for moderate to severe dysplasia by magnification guided punch biopsy: a meta-analysis.

Authors:  Wm Christopher Mathews; Wollelaw Agmas; Edward Cachay
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.